Multiple Sclerosis: Expanded Treatment Options Improve Outcomes for a Disabling Chronic Condition
Therapeutic advances over the past decade have offered MS patients more convenient options with improved treatment outcomes.
Today there are 40 medicines in development to treat MS, offering even greater opportunity to transform the landscape of treatment. Researchers continue to focus on meeting the unmet needs of patients with the progressive form of MS, who presently lack available treatment options. Experimental antibody medicines targeting a protein involved in MS which inhibits the production of myelin are among the innovative approaches demonstrating significant potential for MS patients—including those with the progressive form of the disease. Remarkable progress has been made over the past decade, but research and development continues to provide hope for patients struggling with this diverse and debilitating chronic disease.